Date: Thursday, March 18, 2010
Time: 11:00 a.m. - 12:00 p.m. CST
Pre-Register online now! We will contact you to arrange payment.
Program Content and Objectives
Pharmaceutical and medical device companies' financial relationships with physicians are a large and growing focus of OIG and DOJ enforcement activity. That makes it more important than ever to ensure that these arrangements can withstand critical examination. Determining fair market value (FMV) fees is difficult, and little practical guidance is available. Old ways of valuing professional services -- surveys of historical data, opportunity cost, etc. -- are no longer good enough. Finding a defensible way to value the specialized services physicians provide as speakers, advisory board members, clinical researchers, etc. is central -- but not the whole answer to the FMV challenge.
Compliance questions typically start with defensible methodology, but increasingly focus on consistency of practice across business and functional groups, ensuring transparency, and the broader framework for handling consultative relationships with providers.
This webinar will provide guidance on how to structure defensible fee determinations, and how to ensure that your broader FMV framework can stand up to the heightened scrutiny that is part of today's compliance environment. Key topics will include:
- Key compliance risk issues surrounding FMV determinations
- What the guidance says that is useful
- Criteria for a defensible FMV methodology
- Critical elements of a broader commercial relationship management framework
The session will provide you with the latest insight on mitigating FMV risk, and a concise approach for evaluating your current framework. Wherever you are on the FMV learning curve, this session will leave you clearer about what you’ve got in place, and what you might need to prepare for OIG’s evolving expectations.
The one-hour session will include a 35-40 minute discussion and review of critical FMV issues, and 20-25 minutes for Q&A.
Presenter
Stephen Rothenberg, J.D., Numerof & Associates, Inc.
Mr. Rothenberg has extensive experience assisting clients across functional areas in the pharmaceutical and medical device industries. He’s supported compliance functions in auditing and monitoring, risk assessment, and development and implementation of fair market value determination processes. His legal experience positions him to effectively identify emergent compliance trends and enforcement priorities as guidance to clients. He received his law degree from Washington University in St. Louis.
Who Should Attend
Executive leaders who are increasingly being held accountable by OIG for compliance gaps, and all staff concerned with ensuring regulatory compliance in the pharmaceutical, medical device, diagnostics, and biologics sectors.
Pricing and Registration
|
By 03/10/10 |
After 03/10/10 |
| Individual Participant (one login) |
$195 |
$245 |
| Per Additional Attendee (same login) |
$50 |
$75 |
| Per Additional Attendee (separate login) |
$95 |
$120 |
Pre-Register online now! We will call you to arrange payment.
For more information, contact us
here or call 314-997-1587.